67 related articles for article (PubMed ID: 25891023)
1. KLKB1 mRNA overexpression: A novel molecular biomarker for the diagnosis of chronic lymphocytic leukemia.
Adamopoulos PG; Kontos CK; Papageorgiou SG; Pappa V; Scorilas A
Clin Biochem; 2015 Sep; 48(13-14):849-54. PubMed ID: 25891023
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis.
Papageorgiou SG; Kontos CK; Diamantopoulos MA; Bouchla A; Glezou E; Bazani E; Pappa V; Scorilas A
Dis Markers; 2017; 2017():2046545. PubMed ID: 29463948
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Plasma miR-29a Evaluation in Chronic Lymphocytic Leukemia Patients.
Aref S; El Tantawy A; Aref M; El Agdar M; Ayed M
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2439-2444. PubMed ID: 37505778
[TBL] [Abstract][Full Text] [Related]
4. Can Galectin-3 Be a Novel Biomarker in Chronic Lymphocytic Leukemia?
Woś J; Szymańska A; Lehman N; Chocholska S; Zarobkiewicz M; Pożarowski P; Bojarska-Junak A
Cells; 2023 Dec; 13(1):. PubMed ID: 38201234
[TBL] [Abstract][Full Text] [Related]
5. SOLUBLE CD150 ISOFORM LEVEL IN PLASMA OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS.
Gordiienko I; Shcherbina V; Shlapatska L
Exp Oncol; 2024 Feb; 45(4):457-462. PubMed ID: 38328844
[TBL] [Abstract][Full Text] [Related]
6. Expression Pattern and Prognostic Significance of the Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Chronic Lymphocytic Leukemia.
Tomic Vujovic K; Ugrin M; Tosic N; Vukovic V; Marjanovic I; Kostic T; Stankovic S; Otasevic V; Sarac S; Antic D; Pavlovic S; Karan-Djurasevic T
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255996
[TBL] [Abstract][Full Text] [Related]
7. A molecular score by quantitative PCR as a new prognostic tool at diagnosis for chronic lymphocytic leukemia patients.
Stamatopoulos B; Meuleman N; De Bruyn C; Pieters K; Anthoine G; Mineur P; Bron D; Lagneaux L
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862275
[TBL] [Abstract][Full Text] [Related]
8. Kallikrein-Related Peptidases in Prostate Cancer: From Molecular Function to Clinical Application.
Fuhrman-Luck RA; Loessner D; Clements JA
EJIFCC; 2014 Oct; 25(3):269-81. PubMed ID: 27683474
[TBL] [Abstract][Full Text] [Related]
9. CLLU1 as an emerging biomarker in chronic lymphoid leukemia.
Rong C; Liang C; Shen J; Zhang Y; Wang Q; Yang F; Chen Y; Luo Y; Gu M; Gao P; Xia Y; Duan S
Hum Cell; 2024 May; 37(3):625-632. PubMed ID: 38507118
[TBL] [Abstract][Full Text] [Related]
10. Kallikrein-related peptidases.
Lundwall A; Brattsand M
Cell Mol Life Sci; 2008 Jul; 65(13):2019-38. PubMed ID: 18344018
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Potential of Galectin-9 mRNA Expression in Chronic Lymphocytic Leukemia.
Bojarska-Junak A; Kowalska W; Chocholska S; Szymańska A; Tomczak W; Zarobkiewicz MK; Roliński J
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001630
[TBL] [Abstract][Full Text] [Related]
12. Novel circular RNAs of the apoptosis-related BAX and BCL2L12 genes identified in a chronic lymphocytic leukemia cell line using nanopore sequencing.
Kontos CK; Karousi P; Artemaki PI; Abdelgawad A; Dimitriadou A; Machairas NP; Sideris DC; Pappa V; Scorilas A; Batish M; Papageorgiou SG
FEBS Open Bio; 2023 Oct; 13(10):1953-1966. PubMed ID: 37424436
[TBL] [Abstract][Full Text] [Related]
13. Targeting mRNA translation in CLL.
Küppers R
Blood; 2023 Jun; 141(26):3129-3130. PubMed ID: 37383005
[No Abstract] [Full Text] [Related]
14. Sampling time-dependent artifacts in single-cell genomics studies.
Massoni-Badosa R; Iacono G; Moutinho C; Kulis M; Palau N; Marchese D; Rodríguez-Ubreva J; Ballestar E; Rodriguez-Esteban G; Marsal S; Aymerich M; Colomer D; Campo E; Julià A; Martín-Subero JI; Heyn H
Genome Biol; 2020 May; 21(1):112. PubMed ID: 32393363
[TBL] [Abstract][Full Text] [Related]
15. Jumping translocations, a novel finding in chronic lymphocytic leukaemia.
Miller CR; Stephens D; Ruppert AS; Racke F; McFaddin A; Breidenbach H; Lin HJ; Waller K; Bannerman T; Jones JA; Woyach JA; Andritsos LA; Maddocks K; Zhao W; Lozanski G; Flynn JM; Grever M; Byrd JC; Heerema NA
Br J Haematol; 2015 Jul; 170(2):200-7. PubMed ID: 25891862
[TBL] [Abstract][Full Text] [Related]
16. IGHV gene usage and mutational status in follicular lymphoma: Correlations with prognosis and patient age.
Berget E; Molven A; Løkeland T; Helgeland L; Vintermyr OK
Leuk Res; 2015 Jul; 39(7):702-8. PubMed ID: 25900812
[TBL] [Abstract][Full Text] [Related]
17. Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8.
Gounari M; Ntoufa S; Apollonio B; Papakonstantinou N; Ponzoni M; Chu CC; Rossi D; Gaidano G; Chiorazzi N; Stamatopoulos K; Ghia P
Blood; 2015 Jun; 125(23):3580-7. PubMed ID: 25900981
[TBL] [Abstract][Full Text] [Related]
18. Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A.
Zonta F; Pagano MA; Trentin L; Tibaldi E; Frezzato F; Trimarco V; Facco M; Zagotto G; Pavan V; Ribaudo G; Bordin L; Semenzato G; Brunati AM
Blood; 2015 Jun; 125(24):3747-55. PubMed ID: 25931585
[TBL] [Abstract][Full Text] [Related]
19. Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.
Figueroa JA; Reidy A; Mirandola L; Trotter K; Suvorava N; Figueroa A; Konala V; Aulakh A; Littlefield L; Grizzi F; Rahman RL; Jenkins MR; Musgrove B; Radhi S; D'Cunha N; D'Cunha LN; Hermonat PL; Cobos E; Chiriva-Internati M
Int Rev Immunol; 2015 Mar; 34(2):154-87. PubMed ID: 25901860
[TBL] [Abstract][Full Text] [Related]
20. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
